Stockreport

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates [Yahoo! Finance]

BiomX Inc. COmmon Stock  (PHGE) 
PDF BX004 Phase 2b study in Cystic Fibrosis (CF) is now expected to report topline results in H1 2026 following resolved manufacturing delays Company to host conference c [Read more]